Rocket Lab (RKLB) has launched a new at-the-market (ATM) equity offering program allowing up to US$750 million in stock to be sold over time through multiple investment banks. This replaces a prior ATM program capped at US$500 million, under which Rocket Lab had already raised about US$396.6 million before terminating that earlier facility. The stock reacted negatively: shares dropped about 3.5-4.2% in premarket trading on the announcement and is currently down over 10%.
For investors, the larger ATM provides Rocket Lab with additional capital flexibility—likely aimed at supporting growth initiatives, manufacturing expansion (including its planned acquisition of Mynaric), launch capacity build-out, and potentially other M&A. But the price action indicates market concern over dilution and how aggressively the company might draw on this capacity.